US Medicare to revisit coverage of anemia drugs - Reuters UK PDF Print
Reuters UKRBC has already projected a 25 percent decline in sales of Amgen's Epogen from 2011 to 2013, due mostly to a plan by CMS to "bundle" payments for dialysis

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.